68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer

Shanghai Jiao Tong University

Status: Completed

Conditions: IMAGE; Prostate Specific Membrane Antigen; PET/CT

Treatments: Device: total-body PET/CT

Study type: Observational

Funder types: Other

Identifiers

NCT05134064

2018-104

Details and patient eligibility

About

Dual-time point 68Ga-PSMA PET/CT could increase the lesion detection in PCa patients, it remains difficult to perform in clinical practice. The possibility of one-time point 68Ga-PSMA PET/CT imaging could be achieved using a total-body PET/CT.

Enrollment: 66 patients

Sex: Male

Volunteers: No Healthy Volunteers

Inclusion criteria

• primary staging of pathology-confirmed PCa or evidence of BCR with PSA value > 0.2 ng/ml
• positive 68Ga-PSMA findings
• both standard and delayed scans were performed on the total-body PET/CT

Exclusion criteria

• only one scan was performed
• negative PSMA results

Trial design

66 participants in 1 patient group

PCa patients underwent 1 h p.i. PSMA PET/CT imaging and 3 h p.i. PSMA imaging

Treatment:

Device: total-body PET/CT